Nadine Röthling

ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)

Jens Hoeppner, Florian Lordick, Thomas Brunner et al. · BMC Cancer · 2016 · 353 citations · Full text

Medicine, Oncology, Surgery +17

Ruxolitinib in GvHD (RIG) study: a multicenter, randomized phase 2 trial to determine the response rate of Ruxolitinib and best available treatment (BAT) versus BAT in steroid-refractory acute graft-versus-host disease (aGvHD) (NCT02396628)

Nikolas von Bubnoff, Gabriele Ihorst, Olga Grishina et al. · BMC Cancer · 2018 · 55 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Cetuximab plus weekly oxaliplatin/5FU/FA (FUFOX) in 1^st line metastatic gastric cancer. Final results from a multicenter phase II study of the AIO upper GI study group

Florian Lordick, Sylvie Lorenzen, S. Hegewisch-Becker et al. · Journal of Clinical Oncology · 2007 · 40 citations

Medicine, Oncology, Pharmacotherapy +17

Prognostic Factors for Survival in Patients With Unresectable Pancreatic Cancer

Andreas Weber, Victoria Kehl, Tobias Mittermeyer et al. · Pancreas · 2010 · 37 citations

Medicine, Oncology, Surgery +17

Weekly docetaxel monotherapy for advanced gastric or esophagogastric junction cancer

Kathrin Abbrederis, Sylvie Lorenzen, Ludwig Fischer von Weikersthal et al. · Critical Reviews in Oncology/Hematology · 2008 · 14 citations

Medicine, Oncology, Pharmacotherapy +14